Feasibility of electronic patient-reported outcome monitoring and self-management program in aplastic anemia and paroxysmal nocturnal hemoglobinuria-a pilot study (ePRO-AA-PNH).

Bänziger, Silas; Weisshaar, Kimmo; Arokoski, Reetta; Gerull, Sabine; Halter, Jörg; Rovó, Alicia; Bargetzi, Mario; Goede, Jeroen S; Senft, Yuliya; Valenta, Sabine; Passweg, Jakob R; Drexler, Beatrice (2023). Feasibility of electronic patient-reported outcome monitoring and self-management program in aplastic anemia and paroxysmal nocturnal hemoglobinuria-a pilot study (ePRO-AA-PNH). Annals of hematology, 102(1), pp. 199-208. Springer-Verlag 10.1007/s00277-022-05012-5

Preview

Text s00277-022-05012-5.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (715kB) | Preview

INTRODUCTION

Electronic patient-reported outcomes (ePRO) are increasingly recognized in health care, as they have been demonstrated to improve patient outcomes in cancer, but have been less studied in rare hematological diseases. The aim of this study was to develop and test the feasibility of an ePRO system specifically customized for aplastic anemia (AA) and paroxysmal nocturnal hemoglobinuria (PNH).

METHODS

After performing a user-centered design evaluation an ePRO system for AA and PNH patients could be customized and the application was tested by patients and their medical teams for 6 months. Symptom-reporting triggered self-management advice for patients and prompts them to contact clinicians in case of severe symptoms, while the medical team received alerts of severe symptoms for patient care.

RESULTS

All nine included patients showed a high adherence rate to the weekly symptom-reporting (72%) and reported high satisfaction. The system was rated high for usage, comprehensibility, and integration into daily life. Most patients (78%) would continue and all would recommend the application to other AA/PNH patients. Technical performance was rarely a barrier and healthcare providers saw ePRO-AA-PNH as a useful supplement, but the lacking integration into the hospital information system was identified as a major barrier to usage.

CONCLUSION

An ePRO system customized for AA and PNH was feasible in terms of adherence, satisfaction, and performance, showing a high potential for these rare conditions in terms of data collection and patient guidance. However, the integration into clinical workflows is crucial for further routine use.

TRIAL REGISTRATION

ClinicalTrials.gov NCT04128943.

Interest & Impact

Downloads

19 since deposited on 04 Nov 2022
19 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item